IRHYTHM TECHNOLOGIES INC. - COMMON STOCK

iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024

18 Apr 2024 16:05:00 By Nasdaq GlobeNewswire

iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers’ $86.25 Million Option to Purchase Additional Notes

08 Mar 2024 16:30:01 By Nasdaq GlobeNewswire

iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029

04 Mar 2024 23:42:45 By Nasdaq GlobeNewswire

iRhythm Announces Proposed Offering of $450.0 Million of Convertible Senior Notes

04 Mar 2024 06:45:11 By Nasdaq GlobeNewswire

iRhythm Technologies Announces Fourth Quarter and Full Year 2023 Financial Results

22 Feb 2024 16:05:00 By Nasdaq GlobeNewswire

iRhythm Technologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024

08 Feb 2024 16:05:00 By Nasdaq GlobeNewswire

iRhythm Technologies Shares Preliminary Fourth Quarter 2023 Highlights and Business Update at the 42nd Annual J.P. Morgan Healthcare Conference

08 Jan 2024 08:30:00 By Nasdaq GlobeNewswire

Largest Ever Real-World Evidence Study of Ambulatory Cardiac Monitoring Demonstrates Clinical Superiority of iRhythm's Zio Long-Term Continuous Monitoring Service

05 Jan 2024 08:05:00 By Nasdaq GlobeNewswire

iRhythm Technologies Receives European Union’s CE Marking Under Medical Device Regulation (EU MDR) for its Zio® monitor and ZEUS System

03 Jan 2024 08:00:00 By Nasdaq GlobeNewswire

iRhythm Technologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference

26 Dec 2023 16:30:00 By Nasdaq GlobeNewswire

New Research Presented at American Heart Association’s 2023 Scientific Sessions Demonstrates Performance of Continuous Monitoring ECG Data for Improved Prediction of Heart Failure Hospitalization

13 Nov 2023 08:05:00 By Nasdaq GlobeNewswire

iRhythm Technologies Announces Third Quarter 2023 Financial Results

02 Nov 2023 16:05:01 By Nasdaq GlobeNewswire

iRhythm Technologies to Report Third Quarter 2023 Financial Results on November 2, 2023

19 Oct 2023 16:05:00 By Nasdaq GlobeNewswire

iRhythm Launches Next Generation Zio Monitor and Enhanced Zio Service: Its Smallest, Lightest and Thinnest Cardiac Monitor

26 Sep 2023 08:05:00 By Nasdaq GlobeNewswire

iRhythm Technologies to Participate in Two Investor Conferences in September

29 Aug 2023 08:30:00 By Nasdaq GlobeNewswire

Zio Granted High Medical Needs Designation by the Japanese Ministry of Health, Labour, and Welfare

03 Aug 2023 16:10:00 By Nasdaq GlobeNewswire

iRhythm Technologies Announces Second Quarter 2023 Financial Results

03 Aug 2023 16:05:02 By Nasdaq GlobeNewswire

iRhythm Technologies to Report Second Quarter 2023 Financial Results on August 3, 2023

20 Jul 2023 16:05:00 By Nasdaq GlobeNewswire

NAMCP Independent Third-Party Review Validates Value Proposition of iRhythm Zio XT Service to Health Systems and Payers

18 Jul 2023 08:30:00 By Nasdaq GlobeNewswire

iRhythm Technologies Further Strengthens its Board of Directors with Two New Independent Director Appointments

06 Jun 2023 09:00:39 By Nasdaq GlobeNewswire